Physician profile
Prem Kumar
NPI 1124003587
$944.67
in general payments reported to CMS, 2019-2025
17 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $115 · 2021: $52.29 · 2022: $23.17 · 2023: $102 · 2024: $116 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $171.76 | 2019-2023 | Bevespi Aerosphere, Breztri |
| Lilly USA, LLC | $120.95 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $95.87 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $94.60 | 2019-2023 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Exact Sciences Corporation | $83.33 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $74.31 | 2019-2024 | Rybelsus, Ozempic |
| Teva Pharmaceuticals USA, INC. | $72.46 | 2019-2020 | |
| Amgen INC. | $36.81 | 2020-2023 | Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $27.32 | 2019 | |
| Abbvie INC. | $25.52 | 2020 | |
| Vital Connect, INC | $23.28 | 2024 | Vitalpatch Rtm |
| Nestle Healthcare Nutrition INC. | $21.64 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.00 | 2019 | |
| Aytu Biopharma, INC. | $20.14 | 2019 | |
| Glaxosmithkline, LLC. | $19.56 | 2024 | Arexvy, Shingrix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.98 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prem Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.